Tetje Cornelia van der Sluis

4PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 19, 2026
Cell cycle arrest enhances CD8+ T cell effector function by potentiating glucose metabolism and IL-2 signaling.

Floortje J van Haften, Tetje C van der Sluis, Hanna S Hepp

|Nov 29, 2023
Delayed vaccine-induced CD8+ T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication.

Tetje C van der Sluis, Floortje J van Haften, Suzanne van Duikeren

|Jun 14, 2023
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours.

Bastian Kruse, Anthony C Buzzai, Naveen Shridhar

|Jul 08, 2022
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection.

Iris N Pardieck, Tetje C van der Sluis, Esmé T I van der Gracht

Pageof 1